Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry

Rhea-AI Summary

Milestone Scientific (NYSE: MLSS) launched The Wand Ambassador Program to expand peer-to-peer clinical engagement and accelerate adoption of The Wand STA (Single Tooth Anesthesia) System in dentistry.

The pilot started on Dec 8, 2025 with six registered dental professionals and reported early positive feedback and inbound interest. Milestone plans to scale to approximately 250 ambassadors over 12 months, supported by onboarding, centralized learning resources, and tools that track engagement.

Management expects the program, plus expanded social media outreach, to drive ~2–3x growth in product demonstrations and improve demo-to-sales conversion efficiency while remaining capital-efficient.

Key Figures

Pilot ambassadors 6 dental professionals Initial Ambassador Program pilot launched December 8

Planned ambassadors 250 dental professionals Target program scale over the next 12 months

Program horizon 12 months Planned timeframe to scale to 250 ambassadors

Demo growth target 2–3x increase Expected growth in product demonstrations from Ambassador Program and social media

Market Reality Check

$0.2920 Last Close

Volume Volume 561,599 is slightly above the 20-day average of 513,261 (relative volume 1.09x). normal

Technical Shares at $0.3009 are trading below the 200-day MA of $0.64 and 78.39% under the 52-week high.

Peers on Argus

Peers show mixed moves: NEPH +2.32%, HBIO +1.09%, while POCI -0.47%, RVP -1.21%, NXGL -2.75%, suggesting this news is more stock-specific than sector-driven.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 13	Q3 2025 results	Positive	+6.0%	Cost reductions, stable revenue, and improved operating loss metrics.
Nov 13	Earnings call notice	Neutral	+6.0%	Announcement of conference call to discuss Q3 2025 results.
Oct 14	Operational update	Positive	-1.7%	New CEO outlining cost cuts, dental expansion, and growth initiatives.
Oct 14	Compliance notice	Negative	-1.7%	NYSE American non-compliance tied to <b>$3.3M</b> equity and losses.
Sep 22	Board appointment	Positive	-3.6%	Appointment of Dr. Sayed to support CompuFlo pain management strategy.

Pattern Detected

Recent news shows mixed reactions: compliance and cost-control updates often saw aligned moves, while strategic and leadership news sometimes faced negative divergence.

Recent Company History

Over the last few months, Milestone Scientific has focused on cost reductions, operational transformation, and leadership changes. Q3 2025 results on Nov 13 highlighted revenue near $2.4M, a gross margin of 70%, and improved operating loss, with the stock rising 6.03%. Earlier, on Oct 14, the company disclosed NYSE American non-compliance tied to stockholders’ equity of $3.3M, which coincided with a modest decline. The new Ambassador Program fits the ongoing strategy to expand dental adoption and support longer-term growth initiatives.

Market Pulse Summary

This announcement outlines a peer-driven commercial initiative, with an Ambassador Program launched from 6 pilot participants and a target of 250 dental professionals over 12 months. Management expects 2–3x growth in product demonstrations, tying into earlier efforts to expand dental sales and improve financial performance. In light of recent NYSE American compliance issues and going‑concern disclosures, investors may watch actual demo volumes, conversion rates, and subsequent revenue trends to assess impact.

Key Terms

single tooth anesthesia medical

"adoption of The Wand® STA (Single Tooth Anesthesia®) System within the dental market."

Single tooth anesthesia is a dental technique that numbs only one specific tooth and the immediate surrounding tissue, rather than the whole jaw or a larger area. For investors, it matters because products or devices that enable targeted numbness can reduce side effects, shorten procedures, and improve patient comfort—factors that can increase demand, differentiate dental suppliers, and influence adoption in clinics much like a more precise tool boosts efficiency in any trade.

peer-to-peer engagement technical

"a scalable peer-to-peer engagement initiative designed to expand clinical awareness"

Peer-to-peer engagement is direct interaction between people or groups at the same level—such as investors talking to other investors, customers sharing experiences, or employees exchanging feedback—rather than messages coming from a company’s top-down communications. For investors it matters because these grassroots conversations shape market perception, spread information or concerns quickly, and can influence buying, selling and company reputation much like word-of-mouth at a neighborhood gathering affects interest in a local business.

AI-generated analysis. Not financial advice.

Pilot launched with six registered dental professionals; program expected to scale to 250 ambassadors over 12 months

ROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the launch of The Wand® Ambassador Program, a scalable peer-to-peer engagement initiative designed to expand clinical awareness, education, and adoption of The Wand® STA (Single Tooth Anesthesia®) System within the dental market.

The program leverages experienced dental professionals to share real-world clinical insights, workflow considerations, and firsthand experiences with colleagues. This peer-driven approach is intended to increase high-quality engagement with prospective practices and encourage direct interaction with Milestone for product demonstrations, training, and deeper evaluation of the clinical and operational benefits of The Wand STA system.

The Ambassador Program pilot launched on December 8 with six registered dental professionals in select U.S. markets. Milestone reports early positive feedback from the pilot group and strong inbound interest from additional practitioners seeking to participate, reinforcing management’s confidence in the program’s scalability and relevance.

Milestone plans to expand the program to approximately 250 dental professionals over the next 12 months, supported by a structured onboarding and education framework, centralized learning resources, and defined pathways that connect interested practices with Milestone’s commercial and clinical support teams. Internal program tools provide real-time visibility into engagement activity, enabling the company to measure effectiveness, optimize execution, and scale efficiently.

Based on early pilot activity and historical performance metrics, Milestone expects the Ambassador Program—combined with an increased focus on new and emerging social media channels—to drive approximately 2–3x growth in product demonstrations, supporting more informed evaluations and contributing to stronger demo-to-sales conversion efficiency over time. Management believes this represents a capital-efficient way to expand the top of the funnel while preserving sales productivity and return on investment.

Milestone believes the Ambassador Program strengthens market awareness through credible, education-led engagement and complements the company’s existing sales and marketing efforts. The initiative is designed to support broader adoption of The Wand STA system and contribute to sustainable, long-term growth.

Eric C. Hines, Chief Executive Officer of Milestone Scientific, stated, “The early response to our Ambassador Program has been encouraging, both from our initial pilot participants and from the level of interest we’re seeing from other dental professionals who want to get involved. We believe this peer-driven model, supported by disciplined execution and expanded digital outreach, has the potential to meaningfully increase product demonstrations, reinforce clinical confidence, and support long-term value creation for our shareholders.”

About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology^® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2024. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact:         
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

FAQ

What is Milestone Scientific announcing with the Ambassador Program (MLSS) on January 6, 2026?

Milestone announced a peer-to-peer Ambassador Program to expand clinical awareness and adoption of The Wand STA system, starting from a pilot launched Dec 8, 2025.

How many ambassadors does Milestone (MLSS) plan to enroll and over what timeframe?

Milestone plans to scale the program to approximately 250 dental professionals over the next 12 months.

What early results did the MLSS Ambassador Program pilot show?

The pilot with six registered dental professionals reported early positive feedback and strong inbound interest from additional practitioners.

How does Milestone expect the Ambassador Program to affect product demonstrations for MLSS?

Management expects the program, combined with expanded social media, to drive roughly 2–3x growth in product demonstrations.

How will Milestone measure and support Ambassador Program activity (MLSS)?

The company will use structured onboarding, centralized learning resources, defined practice pathways, and internal tools that provide real-time visibility into engagement activity.